BofA Securities initiated coverage on CeriBell with a new price target

11/5/24 7:25:17 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

BofA Securities initiated coverage of CeriBell with a rating of Buy and set a new price target of $32.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CBLL

Date	Price Target	Rating	Analyst
4/4/2025	$32.00	Buy	Ladenburg Thalmann
11/5/2024	$32.00	Buy	BofA Securities
11/5/2024	$30.00	Buy	Canaccord Genuity
11/5/2024	$32.00	Overweight	JP Morgan
11/5/2024	$31.00	Buy	TD Cowen
11/5/2024		Outperform	William Blair